Prostate cancer is among the most common cancers affecting men globally. With rising cases across Africa, Asia, the Middle East, Europe, and North America, access to effective treatment has become essential.
Apalutamide 60 mg Tablets, offered by Cordium Pharmaceuticals Pvt Ltd, provide an advanced androgen receptor inhibitor therapy designed to help patients with specific forms of prostate cancer.
Cordium Pharmaceuticals is committed to supplying high-quality oncology medicines to international markets, including Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa.
What is Apalutamide 60 mg?
Apalutamide is a prescription anti-cancer medicine used to treat:
Non-metastatic castration-resistant prostate cancer (nmCRPC)
Metastatic castration-sensitive prostate cancer (mCSPC)
Certain advanced prostate cancer conditions as determined by oncologists
It works by blocking the action of male hormones (androgens) that stimulate prostate cancer cell growth.
How Does Apalutamide Work?
Apalutamide belongs to a class of medications called androgen receptor inhibitors.
Mechanism of Action:
Blocks androgen receptors
Prevents testosterone from fueling cancer cells
Slows disease progression
Delays metastasis
Improves progression-free survival rates
This targeted therapy is commonly prescribed alongside androgen deprivation therapy (ADT).
Key Benefits of Apalutamide 60 mg Tablets
✓ Advanced Prostate Cancer Management
Helps delay cancer spread and improve patient outcomes.
✓ Proven Clinical Effectiveness
Supported by international clinical studies.
✓ Convenient Oral Administration
Easy-to-take tablet formulation.
✓ Improved Quality of Life
Helps patients maintain daily activities longer.
✓ Global Healthcare Standard Compliance
Manufactured under strict quality control procedures.
Recommended Usage
Dosage: Only as prescribed by a qualified oncologist.
The commonly prescribed regimen is:
240 mg once daily (4 tablets of 60 mg)
Taken with or without food
Continue treatment as directed by the physician
Do not self-medicate.
Possible Side Effects
Patients may experience:
Fatigue
Skin rash
High blood pressure
Joint pain
Weight loss
Diarrhea
Hot flashes
Thyroid changes
Increased risk of falls
Seek immediate medical attention if severe symptoms occur.
Global Demand for Apalutamide is Growing
The increasing prevalence of prostate cancer has driven demand in emerging and developed healthcare markets.
Target Countries:
🇰🇪 Kenya
Growing oncology infrastructure
Increasing access to specialty medicines
🇳🇬 Nigeria
Rising demand for affordable cancer therapies
🇬🇭 Ghana
Expanding cancer treatment centers
🇵🇭 Philippines
Strong pharmaceutical import market
🇻🇳 Vietnam
Rapidly developing oncology sector
🇦🇪 UAE
Advanced healthcare ecosystem
🇸🇦 Saudi Arabia
Government-supported cancer programs
🇺🇿 Uzbekistan
Expanding pharmaceutical imports
🇰🇿 Kazakhstan
Increasing investment in oncology care
🇺🇸 USA
High demand for quality oncology treatments
🇬🇧 UK
Strong focus on innovative cancer therapies
🇿🇦 South Africa
Growing access to advanced prostate cancer treatment
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd is a trusted Indian pharmaceutical company specializing in global healthcare solutions.
Our Strengths:
✅ Quality-Assured Manufacturing
✅ WHO-GMP Standards
✅ Global Export Expertise
✅ Competitive Pricing
✅ Reliable Supply Chain
✅ Oncology Product Portfolio
✅ Regulatory Documentation Support
✅ Timely International Deliveries
Industries We Serve
Hospitals
Oncology Centers
Government Tenders
Pharmaceutical Importers
Cancer Specialty Clinics
International Distributors
Healthcare Procurement Agencies
Important Medical Disclaimer
Apalutamide 60 mg Tablets are prescription-only medicines.
This article is intended for educational and informational purposes only and should not replace professional medical advice, diagnosis, or treatment. Patients must consult qualified healthcare professionals before starting or changing any cancer treatment.
Apalutamide 60 mg Tablets, offered by Cordium Pharmaceuticals Pvt Ltd, provide an advanced androgen receptor inhibitor therapy designed to help patients with specific forms of prostate cancer.
Cordium Pharmaceuticals is committed to supplying high-quality oncology medicines to international markets, including Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa.
What is Apalutamide 60 mg?
Apalutamide is a prescription anti-cancer medicine used to treat:
Non-metastatic castration-resistant prostate cancer (nmCRPC)
Metastatic castration-sensitive prostate cancer (mCSPC)
Certain advanced prostate cancer conditions as determined by oncologists
It works by blocking the action of male hormones (androgens) that stimulate prostate cancer cell growth.
How Does Apalutamide Work?
Apalutamide belongs to a class of medications called androgen receptor inhibitors.
Mechanism of Action:
Blocks androgen receptors
Prevents testosterone from fueling cancer cells
Slows disease progression
Delays metastasis
Improves progression-free survival rates
This targeted therapy is commonly prescribed alongside androgen deprivation therapy (ADT).
Key Benefits of Apalutamide 60 mg Tablets
✓ Advanced Prostate Cancer Management
Helps delay cancer spread and improve patient outcomes.
✓ Proven Clinical Effectiveness
Supported by international clinical studies.
✓ Convenient Oral Administration
Easy-to-take tablet formulation.
✓ Improved Quality of Life
Helps patients maintain daily activities longer.
✓ Global Healthcare Standard Compliance
Manufactured under strict quality control procedures.
Recommended Usage
Dosage: Only as prescribed by a qualified oncologist.
The commonly prescribed regimen is:
240 mg once daily (4 tablets of 60 mg)
Taken with or without food
Continue treatment as directed by the physician
Do not self-medicate.
Possible Side Effects
Patients may experience:
Fatigue
Skin rash
High blood pressure
Joint pain
Weight loss
Diarrhea
Hot flashes
Thyroid changes
Increased risk of falls
Seek immediate medical attention if severe symptoms occur.
Global Demand for Apalutamide is Growing
The increasing prevalence of prostate cancer has driven demand in emerging and developed healthcare markets.
Target Countries:
🇰🇪 Kenya
Growing oncology infrastructure
Increasing access to specialty medicines
🇳🇬 Nigeria
Rising demand for affordable cancer therapies
🇬🇭 Ghana
Expanding cancer treatment centers
🇵🇭 Philippines
Strong pharmaceutical import market
🇻🇳 Vietnam
Rapidly developing oncology sector
🇦🇪 UAE
Advanced healthcare ecosystem
🇸🇦 Saudi Arabia
Government-supported cancer programs
🇺🇿 Uzbekistan
Expanding pharmaceutical imports
🇰🇿 Kazakhstan
Increasing investment in oncology care
🇺🇸 USA
High demand for quality oncology treatments
🇬🇧 UK
Strong focus on innovative cancer therapies
🇿🇦 South Africa
Growing access to advanced prostate cancer treatment
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd is a trusted Indian pharmaceutical company specializing in global healthcare solutions.
Our Strengths:
✅ Quality-Assured Manufacturing
✅ WHO-GMP Standards
✅ Global Export Expertise
✅ Competitive Pricing
✅ Reliable Supply Chain
✅ Oncology Product Portfolio
✅ Regulatory Documentation Support
✅ Timely International Deliveries
Industries We Serve
Hospitals
Oncology Centers
Government Tenders
Pharmaceutical Importers
Cancer Specialty Clinics
International Distributors
Healthcare Procurement Agencies
Important Medical Disclaimer
Apalutamide 60 mg Tablets are prescription-only medicines.
This article is intended for educational and informational purposes only and should not replace professional medical advice, diagnosis, or treatment. Patients must consult qualified healthcare professionals before starting or changing any cancer treatment.
Keywords
